Home>Topics>Finance>Ceos>David Pyott

David Pyott

  1. All
  2. Commentary
  3. Headlines
  1. Allergan's (AGN) CEO David Pyott on Q2 2014 Results - Earnings Call Transcript

    Headlines

    Mon, 21 Jul 2014

    Q2 2014 Earnings Conference Call July 21, 2014, 10:30 AM ET Executives Jim Hindman - SVP, Treasury, Risk & IR David Pyott - Chairman & CEO Jeff Edwards - EVP, Finance & Business Development, CFO Scott Whitcup - EVP, R&D, Chief Scientific

  2. From Barron’s, December 30, 2013 (Part 2)

    Commentary

    Sat, 28 Dec 2013

    BRK-A/B, DIS, GPS, JNJ, MCK, PAYX, PEP, PFE, PM, UNP ; pg 34]; Allergan [ AGN ; the CEO spotlight on David Pyott ; pg 36]. KO story http://online.barrons.com/article/SB50001424053111904742804579282313576005116.html

  3. Allergan's President Jumps to CEO Position at Hospira

    Commentary

    Tue, 8 Mar 2011

    board members, including founder Gavin Herbert. Although these losses are unfortunate, we think Allergan, under CEO David Pyott 's leadership, continues to have a very talented and experienced management team and board. Pyott will assume Ball

Content Partners